Skip to main content
Friday
October 10, 2025
Sign In
Subscribe
Latest
Economy
Banking
Stocks
Industry
Analysis
Bazaar
RMG
Corporates
Aviation
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Get the Paper
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Explainer
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
FRIDAY,
OCTOBER 10, 2025
J&J
J&J
J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies
No Omicron deaths in J&J vaccine study in South Africa, scientist says
Healthcare giant Johnson & Johnson to split into two companies
US brokers J&J-COVAX deal to send vaccines to conflict zones -Blinken
J&J settles most Risperdal lawsuits, with $800 million in expenses
US FDA clears Moderna, J&J Covid-19 boosters, backs use of different vaccine for boost
Moderna or Pfizer booster works better for people vaccinated with J&J: study
Six US states do not join $26 billion opioid settlements with distributors, J&J
J&J says US FDA agrees to extend shelf life of its Covid-19 vaccine
J&J exploring putting talc liabilities into bankruptcy
J&J reaches $230 mln opioid settlement with New York state
The real vaccine crisis isn’t about J&J or AstraZeneca
J&J to deliver Covid vaccine to Europe from April 19
Show More